Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Endoscopic full-thickness resection of a gastric subepithelial tumor.

Dedania B, Mistry T, Buryanek J, Singhal S.

VideoGIE. 2018 Jan 17;3(3):79-80. doi: 10.1016/j.vgie.2017.11.008. eCollection 2018 Mar. No abstract available.

2.

Hodgkin׳s Lymphoma Presenting as a Cavitary Lung Mass.

Sanchez Petitto G, Jain P, Aisenberg GM, Al Salihi S, Buryanek J.

Am J Med Sci. 2017 Oct;354(4):441. doi: 10.1016/j.amjms.2017.03.009. Epub 2017 Mar 6. No abstract available.

PMID:
29078853
3.

Morphoproteomics, E6/E7 in-situ hybridization, and biomedical analytics define the etiopathogenesis of HPV-associated oropharyngeal carcinoma and provide targeted therapeutic options.

Brown RE, Naqvi S, McGuire MF, Buryanek J, Karni RJ.

J Otolaryngol Head Neck Surg. 2017 Aug 17;46(1):52. doi: 10.1186/s40463-017-0230-2.

4.
5.

Morphoproteomic-Guided Treatment of Chemotherapy Resistant Colon Cancer using Natural Based Therapies: A Case Study.

Rogers JT, Brown RE, Buryanek JJ, Weerasinghe P.

Ann Clin Lab Sci. 2017 Mar;47(2):217-220.

PMID:
28442526
6.

Large Epigastric Cystic Lesion in a Pregnant Woman.

Santamaria-Barria JA, Buryanek J, Ikoma N.

JAMA Oncol. 2017 Apr 1;3(4):557-558. doi: 10.1001/jamaoncol.2016.5846. No abstract available.

PMID:
28114457
7.
8.

Durable response of glioblastoma to adjuvant therapy consisting of temozolomide and a weekly dose of AMD3100 (plerixafor), a CXCR4 inhibitor, together with lapatinib, metformin and niacinamide.

Rios A, Hsu SH, Blanco A, Buryanek J, Day AL, McGuire MF, Brown RE.

Oncoscience. 2016 Jun 11;3(5-6):156-63. doi: 10.18632/oncoscience.311. eCollection 2016.

9.
11.

Carcinosarcoma of the parotid: investigating its biology with morphoproteomics.

Vélez-Pérez A, Huang RS, Everett JM, Guo S, Buryanek J, Karni RJ, Brown RE.

Int J Surg Pathol. 2015 Apr;23(2):116-21. doi: 10.1177/1066896914562278. Epub 2014 Dec 16.

PMID:
25515562
12.

A rare case of incidental retroperitoneal seminoma diagnosed by endoscopic ultrasound-guided fine-needle aspiration.

Thosani N, Ferguson K, Buryanek J, Lesslie D, Spinn MP.

Endosc Ultrasound. 2014 Jan;3(1):66-7. doi: 10.4103/2303-9027.127129. No abstract available.

13.
14.

A novel immunomodulatory molecularly targeted strategy for refractory Hodgkin's lymphoma.

Subbiah V, Brown RE, McGuire MF, Buryanek J, Janku F, Younes A, Hong D.

Oncotarget. 2014 Jan 15;5(1):95-102.

15.

Morphoproteomic profiling of the mammalian target of rapamycin (mTOR) signaling pathway in desmoplastic small round cell tumor (EWS/WT1), Ewing's sarcoma (EWS/FLI1) and Wilms' tumor(WT1).

Subbiah V, Brown RE, Jiang Y, Buryanek J, Hayes-Jordan A, Kurzrock R, Anderson PM.

PLoS One. 2013 Jul 29;8(7):e68985. doi: 10.1371/journal.pone.0068985. Print 2013.

16.

Aortic intimal sarcoma: report of two cases with immunohistochemical analysis for pathogenesis.

Stewart B, Manglik N, Zhao B, Buryanek J, Khalil K, Aronson JF, Buja LM.

Cardiovasc Pathol. 2013 Sep-Oct;22(5):351-6. doi: 10.1016/j.carpath.2013.03.005. Epub 2013 Apr 28.

PMID:
23628153
17.

Sinonasal undifferentiated carcinoma (SNUC): morphoproteomic-guided treatment paradigm with clinical efficacy.

Ansari M, Guo S, Fakhri S, Citardi MJ, Blanco A, Patino M, Buryanek J, Amato R, Karni R, Brown RE.

Ann Clin Lab Sci. 2013 Winter;43(1):45-53.

PMID:
23462605
18.

Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonist.

Subbiah V, Brown RE, Buryanek J, Trent J, Ashkenazi A, Herbst R, Kurzrock R.

Mol Cancer Ther. 2012 Nov;11(11):2541-6. doi: 10.1158/1535-7163.MCT-12-0358. Epub 2012 Aug 20.

19.

Preliminary experience with personalized and targeted therapy for pediatric brain tumors.

Wolff JE, Brown RE, Buryanek J, Pfister S, Vats TS, Rytting ME.

Pediatr Blood Cancer. 2012 Jul 15;59(1):27-33. doi: 10.1002/pbc.23402. Epub 2011 Dec 11.

PMID:
22162424

Supplemental Content

Loading ...
Support Center